Renowned expertise in
several therapeutic areas
LXO Group is committed to continue bringing proven solutions to market where medical needs are crucial and where our medications can make a real difference. We are also committed to optimizing mature medicines by improving their formulations, exploring new indications, and enhancing their effectiveness.
The choice of these therapeutic areas reflects our desire to respond to the most pressing healthcare needs, where our expertise can have a significant impact. We seek to maximise the benefits for patients, while getting the most out of medications that have demonstrated their efficacy and safety over the long term
CVS
Our expertise…
Cardiovascular diseases, such as hypertension, arrhythmia and heart failure, are among the leading causes of death worldwide. Our cardiology medicines are recognised for their efficacy, improving patients’ quality of life and preventing serious complications.
…in cardiology
CNS
Our expertise…
Neurodegenerative diseases, Parkinson’s disease and subarachnoid haemorrhage are all neurological disorders affecting millions of people around the world.
…in neurology
, which was acquired in 2023, is highly regarded by neurology professionals.
Value added medicine
Our expertise…
We are committed to protecting family health by offering tried-and-tested medicines that have been proven effective and safe for years. Our expertise lies in managing mature treatments that are adapted to the everyday needs of families.
…
By guaranteeing long-term access to trusted therapeutic solutions, we are contributing to prevention and well-being for everyone, while responding to public health issues.
Would you like to learn more about the LXO group?
Whether you are looking for high-quality medications or want to join our collective journey, you are in the right place.